Early research (Phase 1)Study completedNCT05533008
What this trial is testing
CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients
Who this might be right for
Hemodialysis
Cara Therapeutics, Inc. 35